Program - Society of Toxicology
Program - Society of Toxicology
Program - Society of Toxicology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
44 th Annual Meeting<br />
and ToxExpo<br />
<strong>Program</strong> Description<br />
#1166 ROLE OF EUKARYOTIC TRANSLATION<br />
INITIATION FACTOR 4E (EIF4E) IN CADMIUM-<br />
INDUCED CYTOTOXICITY AND CELL DEATH.<br />
S. Othumpangat and P. Joseph. <strong>Toxicology</strong> and<br />
Molecular Biology Branch, NIOSH, Morgantown, WV.<br />
#1167 MECHANISMS OF ARSENITE-STIMULATED<br />
HEMEOXYGENASE-1 UPREGULATION IN<br />
HUMAN KERATINOCYTES. K. L. Cooper and L. G.<br />
Hudson. College <strong>of</strong> Pharmacy, University <strong>of</strong> NM,<br />
Albuquerque, NM.<br />
#1168 MERCURY, CADMIUM, ZINC, AND ARSENITE<br />
INHIBIT PAX3 DNA BINDING VIA THE PAIRED<br />
DOMAIN. F. A. Leal 1 , A. F. Machado 2 , M. D. Collins 1<br />
and J. M. Fukuto 1 . 1 Molecular <strong>Toxicology</strong> IDP,<br />
University <strong>of</strong> California, Los Angeles, CA and<br />
2 Department <strong>of</strong> Environmental and Occupational<br />
Health, California State University, Northridge, CA.<br />
Sponsor: O. Hankinson.<br />
#1169 NFκB MEDIATES ZINC-INDUCED COX-2<br />
EXPRESSION IN HUMAN BRONCHIAL<br />
EPITHELIAL CELLS. W. wu 1 . 1 Center for<br />
Environmental Medicine, University <strong>of</strong> North Carolina,<br />
Chapel Hill, NC and 2 Human Studies Division, U.S.<br />
EPA, Research Triangle Park, NC. Sponsor: M.<br />
Madden.<br />
Tuesday Afternoon, March 8<br />
1:30 PM to 4:30 PM<br />
Exhibit Hall<br />
POSTER SESSION: PHARMACEUTICALS-METHODS OF<br />
EVALUATION<br />
Chairperson(s): Patrick Hayden, MatTek Corporation, Ashland, MA.<br />
Displayed: 1:30 PM–4:30 PM<br />
Attended: 3:00 PM–4:30 PM<br />
#1170 COMPARISON OF BCNU AND SARCNU<br />
TOXICITY IN LONG-TERM CULTURES OF<br />
PRECISION-CUT LUNG SLICES. C. A. Tyson, K.<br />
Amin, C. Ip and H. P. Behrsing. <strong>Toxicology</strong> Laboratory,<br />
SRI International, Menlo Park, CA.<br />
#1171 A HIGH-THROUGHPUT IN VITRO MODEL OF<br />
HUMAN TRACHEAL/BRONCHIAL<br />
EPITHELIUM (EPIAIRWAY) FOR PRECLINICAL<br />
SAFETY AND EFFICACY TESTING OF<br />
PHARMACEUTICALS. P. J. Hayden, G. R. Jackson,<br />
J. Kubilus, J. E. Sheasgreen and M. Klausner. MatTek<br />
Corp., Ashland, MA.<br />
#1172 VASCULAR PERMEABILITY IN THE RAT. S.<br />
Rowton and P. Robinson. Covance Laboratories Ltd.,<br />
Harrogate, United Kingdom. Sponsor: D. Everett.<br />
#1173 REDUCED STRESS IN GROUP HOUSED NON-<br />
HUMAN PRIMATES. S. Grainger 1 , J. Hedley 1 and M.<br />
Nieh<strong>of</strong> 2 . 1 Covance Laboratories Ltd., Harrogate, United<br />
Kingdom and 2 Covance Laboratories GmbH, Munster,<br />
Germany. Sponsor: D. Everett.<br />
#1174 PREDICTING ANTIEPILEPTIC DRUG<br />
TOXICITY USING HEPATIC PROTEIN<br />
COVALENT BINDING AND GENE EXPRESSION<br />
POTENTIAL. A. M. Leone 1 , L. M. Kao 1 , M.<br />
McMillian 1 , A. Y. Nie 1 , J. B. Parker 1 , M. F. Kelley 1 , M.<br />
D. Johnson 1 , E. Usuki 2 , A. Parkinson 2 and P. Lord 1 .<br />
1 Mechanistic <strong>Toxicology</strong>, Johnson & Johnson<br />
Pharmaceutical Research & Development, L.L.C.,<br />
Raritan, NJ and 2 XenoTech LLC, Lenexa, KS.<br />
#1175 IN VIVO AND IN VITRO NON-CLINICAL DRUG<br />
SAFETY ASSESSMENT: A KEY PARTNER FOR<br />
ANTICANCER DRUG DEVELOPMENT. N. Lhote 1 ,<br />
Y. Sibiril 3 , D. Bazot 1 , A. Beamonte 1 , J. Delongeas 1 , D.<br />
Parent-Massin 3 and N. Claude 2 . 1 Servier Group, Gidy,<br />
France, 2 Servier Group, Courbevoie, France and 3 LTA<br />
EA3880, UBO Brest, France.<br />
#1176 PHARMACOKINETICS AND ENHANCED ORAL<br />
BIOAVAILABILITY OF NANOSTRUCTURED<br />
DRUG CRYSTALS: COMPARISON OF<br />
PARTICLE ENGINEERING TECHNOLOGIES<br />
FOR DANAZOL, KETOCONAZOLE AND<br />
NAPROXEN IN BEAGLE DOGS. G. G.<br />
Kupperblatt 2 , S. A. Saghir 1 , D. A. Markham 1 , T. L.<br />
Rogers 2 , C. J. Tucker 3 , J. E. Hitt 2 and E. J. Elder 2 .<br />
1 <strong>Toxicology</strong> & Environmental Research & Consulting,<br />
The Dow Chemical Company, Midland, MI,<br />
2 Dowpharma, The Dow Chemical Company, Midland,<br />
MI and 3 Corporate R&D, The Dow Chemical Company,<br />
Midland, MI.<br />
#1177 REDUCTION AND REFINEMENT IN<br />
RADIOLABELLED PRIMATE METABOLISM<br />
STUDIES. J. Kelly, J. Hedley and R. Allen. Covance<br />
Laboratories Ltd., Harrogate, United Kingdom.<br />
Sponsor: D. Everett.<br />
#1178 ADJUVANT ARTHRITIS IN THE MALE LEWIS<br />
RAT. S. Rowton and P. Robinson. Covance<br />
Laboratories Ltd., Harrogate, United Kingdom.<br />
Sponsor: D. Everett.<br />
Tuesday Afternoon, March 8<br />
1:30 PM to 4:30 PM<br />
Exhibit Hall<br />
POSTER SESSION: SAFETY EVALUATION-NON<br />
PHARMACEUTICAL<br />
Chairperson(s): Eugenia Theophilus, R.J. Reynolds Tobacco Company,<br />
Winston Salem, NC.<br />
Displayed: 1:30 PM–4:30 PM<br />
Attended: 1:30 PM–3:00 PM<br />
#1179 EVALUATION OF GENOTOXICITY AND<br />
SENSITIZATION POTENTIAL OF PEPTIDE<br />
COUPLING REAGENTS. D. A. Seid 1 , S. S. Kim 2 and<br />
S. Kim 1 . 1 Applied Biosystems, Foster City, CA and<br />
2 University <strong>of</strong> California, Berkeley, CA.<br />
#1180 COMPARISON OF PHOTOTOXICITY TESTING<br />
METHODS USED TO SCREEN LEAD<br />
COMPOUNDS L. LEE, G. STEVENS, AND B.<br />
JESSEN. PFIZER GLOBAL R&D. L. Lee. Pfizer<br />
Global R&D, San Diego, CA. Sponsor: G. Stevens.<br />
TUESDAY<br />
up-to-date information at www.toxicology.org 139